Biostatistical services, adaptive trials, adaptive trial design, patient safety, IXRS, ePRO, adaptive studies

Adaptive Trial Design

Almac’s suite of technologies and biostatistical services seamlessly implement and support adaptive trial design. Well-designed adaptive trials result in lower drug development costs, reduced time to market, faster go/no-go-decisions, and improved patient safety.

Our IXRS and ePRO tools capture safety and efficacy data and make it viewable in real-time, so that sponsors have the information to take action as predetermined in the protocol. The flexibility of IXRS facilitates making changes (e.g., dropping or adding treatment arms, changing doses,) during the course of a trial.

Almac has implemented more than 100 adaptive studies and has established the reputation as a market leader.

Flash replacement image